4//SEC Filing
Suria Hamza 4
Accession 0001209191-21-062481
CIK 0001370053other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 5:53 PM ET
Size
11.9 KB
Accession
0001209191-21-062481
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
Suria Hamza
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Common Stock
2021-11-01$1.12/sh+36,646$41,044→ 104,282 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-01−36,646→ 36,645 totalExercise: $1.12Exp: 2022-01-31→ Common Stock (36,646 underlying) - Sale
Common Stock
2021-11-01$32.88/sh−2,559$84,139→ 67,636 total - Sale
Common Stock
2021-11-01$32.27/sh−34,087$1,099,967→ 70,195 total
Footnotes (5)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.84 to $32.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.85 to $32.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F4]The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022.
- [F5]In addition to the remaining options to purchase 36,645 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.
Documents
Issuer
ANAPTYSBIO, INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001654495
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 5:53 PM ET
- Size
- 11.9 KB